Essential medicines and health products

WHO ECDD Member State questionnaire

At its 126th session in January 2010, the Executive Board approved the publication “Guidance on the WHO review of psychoactive substances for international control” (EB126/2010/REC1, Annex 6)1 which requires the Secretariat to request relevant information from Ministers of Health in Member States and to prepare a report for submission to the ECDD.

For this purpose, a questionnaire was designed to gather information on the legitimate use, harmful use, status of national control and potential impact of international control for each substance under evaluation. Member States are invited to collaborate, as in the past, in this process by providing accurate information as requested in the questionnaires and concerning substances under review.

The questionnaires will be analysed by the Secretariat and prepared as a report that will be published on the ECDD website. Questionnaires have been sent directly to focal points nominated by Member States, and are provided below for reference only.

Questionnaires


Benzodiazepines

Fentanyl analogs

Preparations listed in Schedule III of the 1961 Single Convention on Narcotic Drugs

Synthetic cannabinoids

Synthetic Stimulants